Praxis Home Retail Limited PRAXIS NSE
Company Overview
Praxis Home Retail Limited engages in the business of home retailing through departmental stores in India. The company offers range of products, such as living, dining, bedroom, essentials, and office furniture; homewares comprising furnishings, tableware, décor, and kitchenware; and kitchen appliances. It also provides modular solutions, including modular kitchens, kitchen accessories, modular wardrobes, and wardrobe accessories; and customized interior solutions, as well as range of accessories, such as clocks and wall hangings. The company sells its products through its brick-and-mortar stores of home furniture and fashion under the HomeTown brand name, as well as through e-commerce. Praxis Home Retail Limited was founded in 2007 and is based in Mumbai, India.
Why Investors Should Care
Generates a return on equity of 86.3%, reflecting efficient use of shareholder capital.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Mar 2026 Revenue of ₹95.66 Cr (-19.6% YoY); net profit ₹-66.61 Cr.
- Trailing 12 Months Year-on-year growth — revenue -9.0%.
- 5-Year Trend Long-term compounding — revenue CAGR -36.8%, profit CAGR -72.3%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -36.81% |
| 1 Year: | -9.00% |
Compounded Profit Growth
| 5 Years: | -72.33% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | -37.56% |
| 6 Months: | -7.51% |
| 3 Months: | -13.19% |
| 1 Month: | -14.52% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)36.20 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 86.3%.
- Generates positive free cash flow.
CONS
- Revenue declined at -36.8% CAGR over 5 years.
- Earnings shrank at -72.3% CAGR over 5 years.
- Trading 52.8% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Consumer Cyclical).
| # | Name | CMP ₹ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | PRAXIS Praxis Home Retail Limited NSE | 6.65 | -1.65 | ₹123.57 Cr | 0.00% | -65.03% | 86.34% | -36.81% | -72.33% |
| 2 | APOLLOTYRE Apollo Tyres Limited NIFTY_MIDNSE | 449.70 | 20.76 | ₹28,447.18 Cr | 2.47% | 8.02% | 8.72% | 5.36% | 9.48% |
| 3 | AMBER Amber Enterprises India Limited NIFTY_SMALLNSE | 7,425.00 | 147.56 | ₹26,186.32 Cr | 0.00% | 7.70% | 5.58% | 21.79% | 4.16% |
| 4 | ASAHIINDIA Asahi India Glass Limited NIFTY_SMALLNSE | 913.95 | 66.18 | ₹23,299.07 Cr | 0.22% | 10.79% | 8.77% | 7.19% | -1.88% |
| 5 | ARVIND Arvind Limited NSE | 546.10 | 34.78 | ₹14,315.45 Cr | 0.71% | 15.37% | 10.66% | 4.66% | 0.77% |
| 6 | ABLBL ADITYA BIRLA LIFES BRAN L NIFTY_SMALLNSE | 94.66 | 65.28 | ₹11,497.77 Cr | 0.53% | 13.23% | 12.11% | 6.81% | 187.00% |
| 7 | ABFRL Aditya Birla Fashion and Retail Limited NIFTY_SMALLNSE | 63.26 | -9.92 | ₹7,697.33 Cr | 0.00% | -3.16% | -12.69% | -12.87% | -685.08% |
| 8 | ARVINDFASN Arvind Fashions Limited NSE | 459.50 | 50.83 | ₹6,140.86 Cr | 0.35% | 19.57% | 12.99% | 9.01% | 49.46% |
| 9 | ALOKINDS Alok Industries Limited NSE | 11.98 | -8.38 | ₹5,948.36 Cr | 0.00% | -10.94% | 3.46% | -19.17% | 5.16% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in INR.
| Metric | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 27.20 Cr | 23.50 Cr | 21.22 Cr | 26.20 Cr | 24.74 Cr |
| Cost of Revenue | 17.41 Cr | 15.70 Cr | 11.47 Cr | 14.69 Cr | 13.43 Cr |
| Gross Profit | 9.79 Cr | 7.81 Cr | 9.75 Cr | 11.52 Cr | 11.31 Cr |
| Operating Expenses | 21.05 Cr | 21.29 Cr | 20.48 Cr | 19.03 Cr | 24.31 Cr |
| Operating Income | -11.26 Cr | -13.49 Cr | -10.73 Cr | -7.52 Cr | -13.00 Cr |
| EBITDA | -4.16 Cr | -5.95 Cr | 91.10 Cr | -4.79 Cr | -105.16 Cr |
| Interest Expense | 3.40 Cr | 4.90 Cr | 4.87 Cr | 5.57 Cr | 5.83 Cr |
| Pretax Income | -14.39 Cr | -16.47 Cr | 81.04 Cr | -15.89 Cr | -115.30 Cr |
| Tax Provision | 0 | 0 | 0 | 0 | 0 |
| Net Income | -14.39 Cr | -16.47 Cr | 81.04 Cr | -15.89 Cr | -115.30 Cr |
| Diluted EPS | -1.08 | -1.22 | 5.24 | -0.86 | -6.21 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | - | 379.07 Cr | 218.63 Cr | 118.97 Cr | 95.66 Cr |
| Cost of Revenue | - | 214.57 Cr | 113.70 Cr | 69.54 Cr | 55.28 Cr |
| Gross Profit | - | 164.50 Cr | 104.93 Cr | 49.43 Cr | 40.39 Cr |
| Operating Expenses | - | 203.57 Cr | 166.33 Cr | 106.84 Cr | 92.08 Cr |
| Operating Income | - | -39.06 Cr | -61.40 Cr | -57.41 Cr | -51.70 Cr |
| EBITDA | - | 36.77 Cr | -27.36 Cr | 9.19 Cr | -24.80 Cr |
| Interest Expense | - | 21.76 Cr | 22.07 Cr | 16.72 Cr | 21.18 Cr |
| Pretax Income | - | -21.01 Cr | -85.71 Cr | -34.98 Cr | -66.61 Cr |
| Tax Provision | - | 0 | 0 | 0 | 0 |
| Net Income | - | -21.01 Cr | -85.71 Cr | -34.98 Cr | -66.61 Cr |
| Diluted EPS | - | -2.07 | -7.02 | -2.74 | -4.03 |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Total Assets | - | 312.36 Cr | 319.23 Cr | 313.37 Cr | 185.68 Cr |
| Current Assets | - | 187.47 Cr | 185.59 Cr | 171.52 Cr | 55.87 Cr |
| Cash & Equivalents | - | 1.79 Cr | 1.96 Cr | 1.72 Cr | 7.69 Cr |
| Inventory | - | 66.34 Cr | 57.44 Cr | 37.52 Cr | 18.10 Cr |
| Receivables | - | 1.44 Cr | 28.74 L | 12.12 L | 12.95 L |
| Total Liabilities | - | 330.31 Cr | 362.40 Cr | 374.86 Cr | 262.84 Cr |
| Current Liabilities | - | 249.78 Cr | 278.84 Cr | 264.63 Cr | 115.81 Cr |
| Long Term Debt | 8.24 Cr | 5.49 Cr | 0 | - | 34.32 Cr |
| Total Debt | - | 157.40 Cr | 186.10 Cr | 253.60 Cr | 189.31 Cr |
| Total Equity | - | -17.95 Cr | -43.18 Cr | -61.49 Cr | -77.15 Cr |
| Shares Outstanding | - | 9.80 Cr | 13.11 Cr | 13.52 Cr | 18.58 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 74.42 Cr | -28.72 Cr | -27.49 Cr | -37.78 Cr |
| Investing Cash Flow | - | -10.20 Cr | -6.63 Cr | -1.33 Cr | -1.49 Cr |
| Financing Cash Flow | - | -68.92 Cr | 35.52 Cr | 28.58 Cr | 45.24 Cr |
| Capital Expenditure | - | -10.20 Cr | -6.81 Cr | -1.33 Cr | -1.81 Cr |
| Free Cash Flow | - | 64.22 Cr | -35.54 Cr | -28.82 Cr | -39.58 Cr |
| Net Change in Cash | - | -4.71 Cr | 17.52 L | -23.93 L | 5.97 Cr |
Ratios (Annual)
Figures in %.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Margin % | - | 43.4% | 48.0% | 41.5% | 42.2% |
| Operating Margin % | - | -10.3% | -28.1% | -48.3% | -54.0% |
| Net Margin % | - | -5.5% | -39.2% | -29.4% | -69.6% |
| ROE % | - | 117.1% | 198.5% | 56.9% | 86.3% |
| ROCE % | - | -62.4% | -152.0% | -117.8% | -74.0% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for PRAXIS
Praxis Precision Medicines stock hits 52-week high at 366.7 USD - Investing.com
<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxPWmdaVWJRWVR0N05mZFM2OUE4Q01jNnFtSGNFVWUtLUZBbkVuXzMxMG1EbWV6M2puN2hFdEhLOG9EbXRDY3lSWlJuVnp0TzFtcUZfTnBONzgtejlCYWR5WUZucVpCVXNlUDZuVHlrTm5YQ1VVNEw1WmU0bVBFcVRtQmZTSGtqX1dyQWVrem…
Insmed Catapults More Than 30%, Leading A Biotech Rally - Investor's Business Daily
<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxQRmRXeEFhU09taUtPRjQzWFdPNVpqb1BfNmg3d0ZRWTFDX2htWnhGODVfUEh6RnlZZ1EzRlJfUzRuU0xSTHFkZENMQUVuSTk0YkV2eXhSZk1BV1dkNUtBZkhpQjdJSXVmWHVaOHlHekM3Q21ycXJ0WUo4S0c2NDdCeGdpNzhjZTVqeVFGZn…
29 New Praxis Employees Get Stock Units, Four-Year Vesting - stocktitan.net
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxORHhFdU5OMC15aWtrTHoxWTRiUkZwRWpYTm1PSDV6eUNrSVpHVUhwTHFueno0RDRlZm44VmRwRS05dmN2MjhuVlVxcDZaSXlCNUZPYUNxb1VWLWVRVzVOVkdrOEhnZXlfNG9ZdzJxcVV1ZHVndWVwUG1rclpILXBVNlVxaW9oTXRMNU81N2…
Praxis Precision Shares Rally On Price Target Hikes: Analyst Sees Upside As High As 100% For Stock - Stocktwits
<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxPZ3c0dm5hU2NSZE1USngwNnRMTU5fc0dIbmFpOVVUdnZ3OHRDYjVSTzVPTk5qZFFhODZYVnpSSTRNY3NieGtkWFd4bGJyLXdWLTcwQjliRnp2WUtPdmVfQnB3X2F6S296MVBNaFNhbEljYVc0WkVvSjk2LTB4TDBqSmpKNmJoY0VpbXdDej…
Why is Praxis Precision Medicines stock surging today? - Investing.com
<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxQTkpCcWpxY09fcE9pNzRxZlRfeERjTUlZNTlMNnFUOFVkNC1jdjhzcWdiWHVReFFIZVUxTDI5MEVtOThNWHFMeThYMl9tWHg5bkdSNmcyNHJkd19YMF9HdEFWV1FXRGltbDI3allCLVV2RXpNTEdDR3FVQV9aZkJ3NzlvRHFVdEtHZGh0bT…
Praxis Precision Medicines (PRAX) Stock After Mixed POWER1 Trial Results How Does The Valuation Stack Up - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxPb21aOVU4cUhncjFIb0JsVW5rR0s4dGNYYkNuY05hUzBlSWV3aDVOVXQ4b256eTl1R3c2UUlxeUFCZi1ad3FzUXhxbHFYT2FBb0g0QmVRZmZ5OXNad3dhN0xka3I2RGIwbVN0cndvTl9SSTRQaWtERjZRWGtORzhyS0gwZGN1MXNRQWRwd1…
PRAXIS — Frequently Asked Questions
What is the current share price of Praxis Home Retail Limited (PRAXIS)?
As of 2026-08-07 06:31 IST, Praxis Home Retail Limited (PRAXIS) trades at ₹6.65 on NSE. Its 52-week range is ₹5.27 to ₹14.10.
What is the market capitalisation of PRAXIS?
Praxis Home Retail Limited (PRAXIS) has a market capitalisation of ₹123.57 Cr on NSE.
What is the P/E ratio of PRAXIS?
PRAXIS trades at a trailing price-to-earnings (P/E) ratio of -1.65. The industry average P/E is 27.66. Its price-to-book (P/B) ratio is -1.74.
What is the return on equity (ROE) of PRAXIS?
PRAXIS has a return on equity (ROE) of 86.34%. Its return on capital employed (ROCE) is -65.03%.
Is PRAXIS a good stock to buy?
This page provides a data-driven analysis of Praxis Home Retail Limited (PRAXIS), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.